Behavioural Neurology

Behavioural Neurology / 2004 / Article

Open Access

Volume 15 |Article ID 516302 |

Mohamed Farouk Allam, Michael J. Campbell, Amparo Serrano Del Castillo, Rafael Fernández-Crehuet Navajas, "Parkinson’s Disease Protects Against Smoking?", Behavioural Neurology, vol. 15, Article ID 516302, 7 pages, 2004.

Parkinson’s Disease Protects Against Smoking?

Received24 Jan 2005
Accepted24 Jan 2005


Our aim was to estimate the pooled risk of current and former smoking for Parkinson’s disease (PD).We have reviewed all observational studies that evaluated the association between PD risk and smoking habit. Twenty six studies were identified: 21 case-control, 4 cohort and 1 cross-sectional. The cross-sectional study did not compare former with never smokers. These studies were carried out between 1968 and 2000.There was an obvious protective effect of current smoking in the pooled estimate [risk estimate 0.37 (95% confidence interval 0.33 to 0.41)]. Former versus never smokers had pooled risk estimate of 0.84 (95% confidence interval 0.76 to 0.92). Current and former smoking do not, therefore, exert the same protective effect against PD so that it is unnecessary to postulate a biological mechanism through which smoking protects against PD. The results show that the reverse direction of causation is a more probable explanation, i.e. movement disorders of PD protect against smoking. Another explanation is that failure to develop strong smoking habits in early adult life might be a prodromal symptom of the disease and could perhaps be its first clinical manifestation.

Copyright © 2004 Hindawi Publishing Corporation and the authors. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Order printed copiesOrder

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.